SCHEMBL5041933

SCHEMBL5041933

COC(C(=O)O)c1cc(C)ccc1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.38
GAA P10253 1/20 0.38
RAB9A P51151 4/20 0.38
NPC1 O15118 2/20 0.38
MAPT P10636 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
PPARG P37231 2/20 0.37
PPARA Q07869 2/20 0.37
SRC P12931 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
KEAP1 Q14145 1/20 0.36
NFE2L2 Q16236 1/20 0.36
PKM P14618 2/20 0.35
KDM4E B2RXH2 1/20 0.35
HPGD P15428 1/20 0.35
CTSA P10619 1/20 0.35
AKR1C3 P42330 1/20 0.35
AKR1C2 P52895 1/20 0.35
PTGS2 P35354 1/20 0.34
GLA P06280 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5041566 0.82 ALDH1A1 (0.50) ALDH1A1GAARAB9ANPC1SMN1; SMN2
SCHEMBL2349189 0.82 AKR1C3 (0.43) KDM4EAKR1C3AKR1C2PTGS2
SCHEMBL5041168 0.80 IDO1 (0.46) ALDH1A1PPARGPPARAKDM4EHPGD
SCHEMBL510322 0.79 SRC (0.41) SMN1; SMN2PPARASRCL3MBTL1KEAP1
SCHEMBL17724548 0.77 ALDH1A1 (0.51) ALDH1A1GAAL3MBTL1KDM4E
SCHEMBL5037418 0.77 ALDH1A1 (0.51) ALDH1A1GAAL3MBTL1KDM4E
SCHEMBL17321033 0.77 CES2 (0.45) RAB9ANPC1SMN1; SMN2SRCAKR1C3
SCHEMBL24223271 0.77 FFAR4 (0.41)
SCHEMBL17241155 0.76 CES2 (0.45) ALDH1A1GAARAB9ANPC1SMN1; SMN2
SCHEMBL17241158 0.76 CES2 (0.45) ALDH1A1GAARAB9ANPC1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567498-B1 MANDELIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-01-23 EP disclosed
US-7129238-B2 Mandelic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2006-10-31 US disclosed
EP-1567498-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-08-31 EP disclosed
US-20040122057-A1 Novel mandelic acid derivatives HOFFMANN-LA ROCHE INC. 2004-06-24 US disclosed
WO-2004048335-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122057-A1 Novel mandelic acid derivatives F7, F11, F9 ALDH1A1 519/4885GAA 1312/4885RAB9A 124/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.